Inflazyme Pharmaceuticals (T.IZP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Busse who wrote (20)	8/1/1996 10:04:00 AM
From: Sean Janzen	of 1501

Steve, Thanks for your update. Yorkton Securities assisted Micrologix (MBI) with an $11,000,000 private placement in September 1995. For Cdn$1.90 investors received one share and one warrant. Warrants can be exercised at a price of Cdn$2.75. Micrologix will receive an additional Cdn$14.4 million if all the warrants are exercised. Micrologix has traded as high as Cdn$5.4 and currently trades at Cdn$3.30. We can assume all warrants will be exercised. Anyone wanting information on Micrologix should call Dawn Vanzant at 1-800-665-1968. Inflazyme's financial position will be strengthened by the option agreement and the TB antigen deal with Abbott. Additional financing is beneficial if it situates IZP in a position of strength from which to negotiate licensing deals. Just having the potential for additional financing offers IZP the ability to arrange the best possible licensing deals. The cost of additional financing is the addition of shares thus a dilution of the stock. I would like to see Inflazyme hold on as long as possible before finalizing a licensing agreement for Apanol. Any thoughts?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next